| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 4-hydroxybutyrate receptor activity | 4.95e-05 | 2 | 141 | 2 | GO:0062124 | |
| GeneOntologyBiologicalProcess | axon guidance | MYCBP2 NTN3 PTK7 PLEKHG4B ARHGEF40 HMCN2 IGSF9 FGF8 PLA2G10 AGRN | 2.12e-05 | 285 | 137 | 10 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | MYCBP2 NTN3 PTK7 PLEKHG4B ARHGEF40 HMCN2 IGSF9 FGF8 PLA2G10 AGRN | 2.19e-05 | 286 | 137 | 10 | GO:0097485 |
| Domain | Filamin | 6.37e-05 | 11 | 139 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 6.37e-05 | 11 | 139 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 6.37e-05 | 11 | 139 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 6.37e-05 | 11 | 139 | 3 | IPR017868 | |
| Domain | Riboflavin_transptr | 1.64e-04 | 3 | 139 | 2 | IPR009357 | |
| Domain | DUF1011 | 1.64e-04 | 3 | 139 | 2 | PF06237 | |
| Domain | Ig-like_fold | IGSF8 NPHS1 GP6 FLNA FLNC MYCBP2 TSPOAP1 IGSF5 IGDCC4 PTK7 HMCN2 PKHD1 IGSF9 SIGLEC1 IGSF1 | 2.51e-04 | 706 | 139 | 15 | IPR013783 |
| Domain | IGc2 | 3.82e-04 | 235 | 139 | 8 | SM00408 | |
| Domain | Ig_sub2 | 3.82e-04 | 235 | 139 | 8 | IPR003598 | |
| Domain | - | IGSF8 NPHS1 GP6 FLNA FLNC MYCBP2 TSPOAP1 IGSF5 IGDCC4 PTK7 PKHD1 IGSF9 SIGLEC1 IGSF1 | 4.33e-04 | 663 | 139 | 14 | 2.60.40.10 |
| Domain | Ig_I-set | 5.57e-04 | 190 | 139 | 7 | IPR013098 | |
| Domain | I-set | 5.57e-04 | 190 | 139 | 7 | PF07679 | |
| Domain | Kazal_1 | 5.60e-04 | 22 | 139 | 3 | PF00050 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA FLNC SPHK2 MYCBP2 SZT2 PHF12 STK11IP ATP13A2 RYR1 KIAA2013 PLEKHH3 ARHGEF40 MAP1S ADAMTS7 SLC45A3 SEC16A TNK2 SLC52A2 PRDM16 AGRN | 3.38e-08 | 1105 | 144 | 20 | 35748872 |
| Pubmed | 1.52e-06 | 85 | 144 | 6 | 15449545 | ||
| Pubmed | 5.38e-06 | 162 | 144 | 7 | 25826454 | ||
| Pubmed | ATN1 PHF12 GPX1 SIPA1 RAB11FIP1 SUCLG1 FCSK ARHGEF40 HMCN2 ZNF608 WDR6 NEURL1 SEC16A SIGLEC1 PRDM16 TCTN2 | 1.67e-05 | 1116 | 144 | 16 | 31753913 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 20719933 | ||
| Pubmed | Aberrant copy numbers of ALK gene is a frequent genetic alteration in neuroblastomas. | 1.70e-05 | 2 | 144 | 2 | 19656550 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 26829053 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 34861448 | ||
| Pubmed | Activated ALK collaborates with MYCN in neuroblastoma pathogenesis. | 1.70e-05 | 2 | 144 | 2 | 22439933 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 7689010 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 12740431 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 22589245 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 35132576 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 22484425 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 10679933 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 22678901 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 18165268 | ||
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 1.70e-05 | 2 | 144 | 2 | 24469451 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 33637566 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 26791833 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 17244893 | ||
| Pubmed | Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling. | 1.70e-05 | 2 | 144 | 2 | 27707976 | |
| Pubmed | The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma. | 1.70e-05 | 2 | 144 | 2 | 22789543 | |
| Pubmed | Complete Deletion of Slc52a2 Causes Embryonic Lethality in Mice. | 1.70e-05 | 2 | 144 | 2 | 33518683 | |
| Pubmed | ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma. | 1.70e-05 | 2 | 144 | 2 | 24356251 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 22286764 | ||
| Pubmed | Involvement of riboflavin transporter RFVT2/Slc52a2 in hepatic homeostasis of riboflavin in mice. | 1.70e-05 | 2 | 144 | 2 | 23911957 | |
| Pubmed | The prognostic roles of and correlation between ALK and MYCN protein expression in neuroblastoma. | 1.70e-05 | 2 | 144 | 2 | 31542727 | |
| Pubmed | Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice. | 2.07e-05 | 39 | 144 | 4 | 24703692 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 26976849 | ||
| Pubmed | The Expression of Riboflavin Transporters in Human Colorectal Cancer. | 5.09e-05 | 3 | 144 | 2 | 29715086 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 35013309 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 11038172 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 26072523 | ||
| Pubmed | ALK positively regulates MYCN activity through repression of HBP1 expression. | 5.09e-05 | 3 | 144 | 2 | 30538293 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 23506902 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 11102480 | ||
| Pubmed | Filamin A negatively regulates the transcriptional activity of p73alpha in the cytoplasm. | 5.09e-05 | 3 | 144 | 2 | 17825253 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 12393796 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 9412467 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 11153914 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 24139842 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 11252955 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 12704190 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 20844270 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 21342325 | ||
| Pubmed | The ALDH2, IGSF9, and PRDM16 Proteins as Predictive Biomarkers for Prognosis in Breast Cancer. | 5.09e-05 | 3 | 144 | 2 | 36639264 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 20463145 | ||
| Pubmed | 6.55e-05 | 418 | 144 | 9 | 34709266 | ||
| Pubmed | Genetic analysis of 22 candidate genes for hypertension in the Japanese population. | 1.01e-04 | 22 | 144 | 3 | 15167446 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 11739414 | ||
| Pubmed | Structural interaction and functional regulation of polycystin-2 by filamin. | 1.02e-04 | 4 | 144 | 2 | 22802962 | |
| Pubmed | The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and neural development. | 1.02e-04 | 4 | 144 | 2 | 30848386 | |
| Pubmed | iNOS is not responsible for RyR1 S-nitrosylation in mdx mice with truncated dystrophin. | 1.02e-04 | 4 | 144 | 2 | 32693782 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 20554076 | ||
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 22194892 | ||
| Pubmed | The Parkinson's disease-associated genes ATP13A2 and SYT11 regulate autophagy via a common pathway. | 1.02e-04 | 4 | 144 | 2 | 27278822 | |
| Pubmed | 1.39e-04 | 63 | 144 | 4 | 11572484 | ||
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 12006559 | ||
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 17360453 | ||
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 18326824 | ||
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 19366992 | ||
| Pubmed | Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis. | 1.69e-04 | 5 | 144 | 2 | 11818962 | |
| Pubmed | TRIM14 CCDC85A DENND3 KIAA2013 KRBA1 USF3 DSTYK KLHL14 PRDM16 | 2.26e-04 | 493 | 144 | 9 | 15368895 | |
| Pubmed | Vector-capping: a simple method for preparing a high-quality full-length cDNA library. | 2.53e-04 | 6 | 144 | 2 | 16106752 | |
| Pubmed | 2.53e-04 | 6 | 144 | 2 | 9006895 | ||
| Pubmed | 2.53e-04 | 6 | 144 | 2 | 12679033 | ||
| Pubmed | 2.53e-04 | 6 | 144 | 2 | 15585877 | ||
| Pubmed | Conditional deletion of N-Myc disrupts neurosensory and non-sensory development of the ear. | 2.53e-04 | 6 | 144 | 2 | 21448975 | |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 3.06e-04 | 307 | 144 | 7 | 37499664 | |
| Pubmed | 3.53e-04 | 7 | 144 | 2 | 10704889 | ||
| Pubmed | 3.53e-04 | 7 | 144 | 2 | 19815557 | ||
| Pubmed | Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages. | 3.53e-04 | 7 | 144 | 2 | 30655318 | |
| Pubmed | 3.53e-04 | 7 | 144 | 2 | 26929074 | ||
| Pubmed | 3.53e-04 | 7 | 144 | 2 | 16076904 | ||
| Pubmed | Noncanonical imprinting sustains embryonic development and restrains placental overgrowth. | 3.53e-04 | 7 | 144 | 2 | 35483741 | |
| Pubmed | 3.78e-04 | 529 | 144 | 9 | 14621295 | ||
| Pubmed | ATN1 DENND3 PTK7 FREM2 ARHGEF40 WDR6 DSTYK PCDHGC3 AGRN HELLS | 3.96e-04 | 650 | 144 | 10 | 38777146 | |
| Pubmed | 4.54e-04 | 153 | 144 | 5 | 10718198 | ||
| Pubmed | HSPB7 prevents cardiac conduction system defect through maintaining intercalated disc integrity. | 4.69e-04 | 8 | 144 | 2 | 28827800 | |
| Pubmed | MEKK4 signaling regulates filamin expression and neuronal migration. | 4.69e-04 | 8 | 144 | 2 | 17145501 | |
| Pubmed | Genome-wide association study of the child behavior checklist dysregulation profile. | 4.69e-04 | 8 | 144 | 2 | 21784300 | |
| Pubmed | 4.69e-04 | 8 | 144 | 2 | 15831471 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 5.13e-04 | 552 | 144 | 9 | 10737800 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 5.68e-04 | 560 | 144 | 9 | 21653829 | |
| Pubmed | Activities of N-Myc in the developing limb link control of skeletal size with digit separation. | 6.01e-04 | 9 | 144 | 2 | 17360777 | |
| Pubmed | Signaling through Tgf-beta type I receptor Alk5 is required for upper lip fusion. | 6.01e-04 | 9 | 144 | 2 | 18586087 | |
| Pubmed | 6.01e-04 | 9 | 144 | 2 | 32424104 | ||
| Pubmed | 6.01e-04 | 9 | 144 | 2 | 11807098 | ||
| Pubmed | 6.01e-04 | 9 | 144 | 2 | 27487469 | ||
| Pubmed | Comparative mapping of the actin-binding protein 280 genes in human and mouse. | 6.01e-04 | 9 | 144 | 2 | 8088838 | |
| Pubmed | 6.01e-04 | 9 | 144 | 2 | 21858002 | ||
| Pubmed | 6.01e-04 | 9 | 144 | 2 | 30061166 | ||
| Pubmed | 6.70e-04 | 95 | 144 | 4 | 20843830 | ||
| Pubmed | 7.50e-04 | 10 | 144 | 2 | 35216141 | ||
| Pubmed | 9.14e-04 | 11 | 144 | 2 | 36579465 | ||
| Pubmed | The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. | 9.14e-04 | 11 | 144 | 2 | 8617505 | |
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 9.14e-04 | 11 | 144 | 2 | 17023412 | |
| Pubmed | 9.14e-04 | 11 | 144 | 2 | 8581564 | ||
| Pubmed | Fgf8 promotes survival of nephron progenitors by regulating BAX/BAK-mediated apoptosis. | 1.09e-03 | 12 | 144 | 2 | 36527791 | |
| GeneFamily | Immunoglobulin like domain containing | 5.81e-06 | 193 | 91 | 8 | 594 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.62e-04 | 161 | 91 | 6 | 593 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.59e-08 | 162 | 143 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.01e-07 | 175 | 143 | 8 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.01e-07 | 175 | 143 | 8 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 9.95e-07 | 163 | 143 | 7 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.37e-06 | 171 | 143 | 7 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.37e-06 | 171 | 143 | 7 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-06 | 173 | 143 | 7 | b335ca2a247156eba821943b2b9fc9922230b409 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 184 | 143 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.23e-06 | 184 | 143 | 7 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 2.23e-06 | 184 | 143 | 7 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 184 | 143 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 184 | 143 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 2.49e-06 | 187 | 143 | 7 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | (08)_Brush+PNEC-(0)_Reference|(08)_Brush+PNEC / shred by cell type by condition | 3.51e-06 | 197 | 143 | 7 | d500bfed2a76f7300f2f17b60962c18a40efd084 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.27e-05 | 159 | 143 | 6 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.32e-05 | 160 | 143 | 6 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.32e-05 | 160 | 143 | 6 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 165 | 143 | 6 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 165 | 143 | 6 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.62e-05 | 166 | 143 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.73e-05 | 168 | 143 | 6 | c3d2d573f21350a4a674faff30b06ff644d00ac3 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.79e-05 | 169 | 143 | 6 | 0a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 169 | 143 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 1.85e-05 | 170 | 143 | 6 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | COVID-pDC|COVID / Condition, Cell_class and T cell subcluster | 1.98e-05 | 172 | 143 | 6 | 3ecbb000495dde32f6153ef6bdea9c8802ff3985 | |
| ToppCell | COVID-pDC-|COVID / Condition, Cell_class and T cell subcluster | 1.98e-05 | 172 | 143 | 6 | a7827faa1afab51fdaf0cb1a2babcd2e00d411e5 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-05 | 173 | 143 | 6 | 62abaaaf48cabd1423f17fb27c33b75ea88867f4 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-05 | 173 | 143 | 6 | 09cd878c33534bd476d6a4880f5582076189da8c | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 176 | 143 | 6 | 5201f003192c033655ba47f0faf8c47a96eae03d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-05 | 177 | 143 | 6 | f28243b51be104cb3adcde63f03fc2206ed3121e | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 2.33e-05 | 177 | 143 | 6 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 177 | 143 | 6 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 177 | 143 | 6 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 179 | 143 | 6 | dd94ebe69ade6f51b94058abe066216f0de9feda | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.56e-05 | 180 | 143 | 6 | 5861b44acfb8fe92c281c8355bf19c059b3dcd64 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-05 | 181 | 143 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Mild/Remission-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.90e-05 | 184 | 143 | 6 | 3d4864605c812862cf8926e02370eea3b8ccf32f | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 2.98e-05 | 185 | 143 | 6 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.98e-05 | 185 | 143 | 6 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.08e-05 | 186 | 143 | 6 | 31df1eafa3010bc1be6fc4d4689f1393d69b6b13 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.08e-05 | 186 | 143 | 6 | eaa431ccd4cdd36fe06a44987603ec9979025aa8 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.08e-05 | 186 | 143 | 6 | b95be984e308d4f9061274a35995ec558d434e74 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.08e-05 | 186 | 143 | 6 | 8f7949740286f64e034d1eb533ebc2c6f71ae966 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.08e-05 | 186 | 143 | 6 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.08e-05 | 186 | 143 | 6 | 95c7318e521fb6aa02e244b1e81e6b2a62107756 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.08e-05 | 186 | 143 | 6 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.08e-05 | 186 | 143 | 6 | b70cd94c651b56dcf2e55554533a5f1130845390 | |
| ToppCell | COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease group, lineage and cell class | 3.08e-05 | 186 | 143 | 6 | 3db5ed69d49e5d79f990aca0295ddce4c297a05c | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.08e-05 | 186 | 143 | 6 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease group, lineage and cell class | 3.36e-05 | 189 | 143 | 6 | c6cfd6aa21c19f2c62d80218bbc924e14e82aada | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 191 | 143 | 6 | 116fba9badea093e11f370996247cca0e4c02e8f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 193 | 143 | 6 | ab78fb1603ea6f720ba2d30148fe65dccf271fe1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.01e-05 | 195 | 143 | 6 | 06051de72b5c1e0d483a28b14dabd247dfca0ed9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.01e-05 | 195 | 143 | 6 | 3aa44633c72658545aa2b35bf9d532c62f36a451 | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.12e-05 | 196 | 143 | 6 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | (07)_Ionocytes-(0)_Reference|(07)_Ionocytes / shred by cell type by condition | 4.12e-05 | 196 | 143 | 6 | 4ac33e7d11b8b0fff6ee2e9dacad49c21d63b818 | |
| ToppCell | severe-pDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.36e-05 | 198 | 143 | 6 | 22da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6 | |
| ToppCell | severe-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.36e-05 | 198 | 143 | 6 | 3c4820a8391088682fb3e47b914f872533bae227 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.48e-05 | 199 | 143 | 6 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | mLN-ILC-ILC|mLN / Region, Cell class and subclass | 4.48e-05 | 199 | 143 | 6 | ab09a06cdea2597e9fe4b4b304655e9de4d433f6 | |
| ToppCell | mLN-ILC|mLN / Region, Cell class and subclass | 4.48e-05 | 199 | 143 | 6 | d6c299312c747fb1b7c53644c53efc03a5fffe85 | |
| ToppCell | mLN-(3)_ILC|mLN / shred on region, Cell_type, and subtype | 4.48e-05 | 199 | 143 | 6 | 00e0e2a766dd9c4d0a65f53d88fa50df4b6a3d60 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.48e-05 | 199 | 143 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Sepsis-Int-URO-Myeloid-pDC|Int-URO / Disease, condition lineage and cell class | 4.48e-05 | 199 | 143 | 6 | a41c3c3360b1b4546c9b2c49bda595feef6a4a4a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.48e-05 | 199 | 143 | 6 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | mLN-(3)_ILC-(30)_ILC|mLN / shred on region, Cell_type, and subtype | 4.48e-05 | 199 | 143 | 6 | 33ac6d77099076df01299be429f4ba96f2f34cc1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.61e-05 | 200 | 143 | 6 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.84e-05 | 128 | 143 | 5 | 082b3dc312b033c9b21cf73499009a1dc049ee2b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.84e-05 | 128 | 143 | 5 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Ptprz1_(Ptprz1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.80e-05 | 68 | 143 | 4 | 9ce22a6dea3c17d5352572ea0dabe6c6120b9f82 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Ptprz1_(Ptprz1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.80e-05 | 68 | 143 | 4 | 89d337147899a978a7467db24e876a613bdd2288 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.87e-05 | 143 | 143 | 5 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 144 | 143 | 5 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 145 | 143 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Adult-Immune-enucleated_erythrocyte-D175|Adult / Lineage, Cell type, age group and donor | 1.31e-04 | 152 | 143 | 5 | 530d5427d8617dcb223d807b73abee0ef89285f3 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.35e-04 | 81 | 143 | 4 | f7f2adf1fecd34b444de92d4c1bf45eb0281f4ad | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.35e-04 | 81 | 143 | 4 | 8d323402ee5fb450947b00b0d75ca8f07aa4769e | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.35e-04 | 81 | 143 | 4 | 55cbf579d93e14bc4aebbed0fd11076c9313cdac | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.40e-04 | 154 | 143 | 5 | 65dbb60f636562eeba3dafadae9c0c7db2b27476 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-04 | 156 | 143 | 5 | d9d87368e43b24952e70f31f38425e15b716ff5b | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 159 | 143 | 5 | 51bdbacb79227fbee38bb8680c58cb99878df0c7 | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.67e-04 | 160 | 143 | 5 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | LPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-04 | 161 | 143 | 5 | 472c354f5ee148b37a5dfb795e83348ecb1643f1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-04 | 161 | 143 | 5 | 9cfbbcd38ec2e75376bbc26001964b6991ad0e21 | |
| ToppCell | Club_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.72e-04 | 161 | 143 | 5 | 342f5c61d37df61b35c18f5d258043a8f5cef629 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-04 | 163 | 143 | 5 | 63b0badaee3b2d827b1f4524510e3384d8f8fcde | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.82e-04 | 163 | 143 | 5 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-04 | 165 | 143 | 5 | 1a114eacaab598f755a173a3fed842ba91f689dd | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-04 | 165 | 143 | 5 | 9cfd3c1d2c6d714fde83b90465f1f9741b0e50ce | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-04 | 166 | 143 | 5 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-04 | 167 | 143 | 5 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 167 | 143 | 5 | 4ae9f2c5df13463709ea880ab035965fd99e7626 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 167 | 143 | 5 | 4e58f9bf1e9d47720c871776ec34513ded4de9b7 | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.10e-04 | 168 | 143 | 5 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 169 | 143 | 5 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-04 | 169 | 143 | 5 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 169 | 143 | 5 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-04 | 169 | 143 | 5 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-04 | 169 | 143 | 5 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.21e-04 | 170 | 143 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 6.31e-05 | 3 | 136 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 6.31e-05 | 3 | 136 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Brown-Vialetto-Van Laere syndrome (implicated_via_orthology) | 6.31e-05 | 3 | 136 | 2 | DOID:0050694 (implicated_via_orthology) | |
| Disease | Neuroblastoma | 6.60e-05 | 47 | 136 | 4 | C0027819 | |
| Disease | Neural crest tumor | 4.36e-04 | 7 | 136 | 2 | C2931189 | |
| Disease | Unilateral agenesis of kidney | 5.80e-04 | 8 | 136 | 2 | C0266294 | |
| Disease | Parkinson Disease | 6.55e-04 | 85 | 136 | 4 | C0030567 | |
| Disease | Congenital Disorders of Glycosylation | 9.26e-04 | 10 | 136 | 2 | C0282577 | |
| Disease | Congenital muscular dystrophy | 1.35e-03 | 12 | 136 | 2 | cv:C0699743 | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 1.59e-03 | 13 | 136 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.85e-03 | 14 | 136 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 1.85e-03 | 14 | 136 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | lysophosphatidylcholine 15:0 measurement | 1.85e-03 | 14 | 136 | 2 | EFO_0020941 | |
| Disease | Generalized hypotonia | 2.13e-03 | 15 | 136 | 2 | C1858120 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 2.13e-03 | 15 | 136 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | Cardiovascular Abnormalities | 2.43e-03 | 16 | 136 | 2 | C0243050 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 2.74e-03 | 17 | 136 | 2 | C0751883 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.96e-03 | 128 | 136 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.96e-03 | 128 | 136 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.96e-03 | 128 | 136 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.96e-03 | 128 | 136 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.96e-03 | 128 | 136 | 4 | C0007134 | |
| Disease | Disorder of eye | 3.07e-03 | 212 | 136 | 5 | C0015397 | |
| Disease | Feeding difficulties | 3.07e-03 | 18 | 136 | 2 | C0232466 | |
| Disease | wheezing | 3.40e-03 | 65 | 136 | 3 | EFO_0009715 | |
| Disease | anorectal malformation | 3.43e-03 | 19 | 136 | 2 | MONDO_0019938 | |
| Disease | HbA1c measurement | 4.16e-03 | 675 | 136 | 9 | EFO_0004541 | |
| Disease | Hepatitis, Chronic | 4.59e-03 | 22 | 136 | 2 | C0019189 | |
| Disease | Chronic active hepatitis | 4.59e-03 | 22 | 136 | 2 | C0520463 | |
| Disease | Chronic Persistent Hepatitis | 4.59e-03 | 22 | 136 | 2 | C0149519 | |
| Disease | Cryptogenic Chronic Hepatitis | 4.59e-03 | 22 | 136 | 2 | C0524611 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PDVVRVCPGAGGTVI | 61 | Q8NAT2 | |
| SGLVSCLLGPALGPV | 481 | Q03989 | |
| LKCLAPGGGRVQEVP | 121 | Q8TER5 | |
| SVEPGAPGLGNCLRQ | 401 | Q00973 | |
| LLALCPGGRPQTVLT | 16 | Q8IUX7 | |
| GSEGPGKNCVPVIQR | 211 | O14503 | |
| LGPRGLVVLGFPCNQ | 66 | P07203 | |
| IPPGECFGLLGVNGA | 1936 | O95477 | |
| LAQEGRAPVECPSLG | 841 | P54259 | |
| RGGAVCEKVLGAPVP | 1361 | O00468 | |
| GANCGIPLNPARDLG | 206 | Q96PS8 | |
| GPGGLLRAQEQPSCR | 26 | P58335 | |
| GPSPGPGLAVRICAV | 221 | A5YM72 | |
| PEIGVGGQPQICFPR | 46 | A6NGY3 | |
| GVDLLTLPQLCFPGG | 36 | A2RUS2 | |
| CGGGEQQRLVTCPEP | 1536 | Q9UKP4 | |
| QVIQAPGPRAGPCIL | 831 | Q07912 | |
| LSCGVGPLQVILGPE | 36 | Q8TDY8 | |
| LGLECRAQAQPGVPL | 2356 | Q9HC84 | |
| GLECRAQAQPGVPLG | 4171 | Q9HC84 | |
| CVNGELRQALGPGAP | 826 | O95153 | |
| EPALLGLGCDSGQPR | 1361 | O95153 | |
| QTRGGQVSVCPLPRG | 486 | P20702 | |
| RPGVCLVVSGPGLIH | 76 | Q9UJ83 | |
| PGREPSGIIEAICIG | 216 | Q8TAE7 | |
| PITVPGRILGGVCVV | 381 | Q8TAE7 | |
| LELPCVARGGNPLAT | 261 | O60500 | |
| LTILANGPGCIPAVI | 396 | Q8N6Y1 | |
| IQRGVPGPFLVCGPL | 266 | Q9NRZ9 | |
| GILPVRPLRFACVGG | 621 | A5PL33 | |
| RESPLVPIGLGGCLV | 26 | Q9P298 | |
| PGRGIVCSCPEGLQL | 1191 | Q9NZR2 | |
| AGPGEKVVRVLFPGC | 421 | Q66K74 | |
| PRCFTPGEALLVLGG | 186 | Q9UPQ8 | |
| TLLLQCPGGGLPQEQ | 6 | Q9BRQ3 | |
| GLTRCINGTEPGPLL | 391 | P61550 | |
| VSGLVGPVNPAACRP | 121 | Q02846 | |
| GRLGCTRENDPVLGP | 171 | Q9NQ38 | |
| LEGQPVSLPCIVLAG | 896 | Q8NDA2 | |
| EGLCQPRVPGVVGAE | 2506 | Q5SZK8 | |
| PERLCSGPGIVGNVL | 241 | Q9Y5P6 | |
| GCVLGLRPGAQESPV | 436 | Q6ZUT6 | |
| LGLCLGRVPAQSGPL | 11 | Q9HCN6 | |
| RLQPICPIEGRLGGA | 36 | Q8IZT8 | |
| QGLCGLVPEGTLPGA | 231 | Q6ZS72 | |
| GGKRLLIVPPACAVG | 251 | Q5T1M5 | |
| IGIKCAPGVVGPAEA | 801 | Q14315 | |
| PVPVVGLGSLCLGSD | 156 | Q99956 | |
| GLVTIVECGPVLLGP | 376 | O60669 | |
| IVPGRGCAIPNRPGI | 691 | P14210 | |
| PICLVSEGLGQPLGV | 81 | P0CG21 | |
| AGENGLVTCEVPPGL | 381 | Q9UN70 | |
| ELAGTVGCVGPRTPI | 46 | O15496 | |
| AAVPLGALEQGCPIR | 6 | Q8N6N6 | |
| PCQGLRPTVDVLGDL | 226 | Q6XUX3 | |
| PTLGVAPVPCRQAGV | 661 | Q5XG87 | |
| GEPFGICRLAVPVEG | 501 | Q7Z442 | |
| QVPCILVGPGTGIAP | 1246 | P29475 | |
| APRGCVPGLVNAALG | 36 | O00634 | |
| TELGGLAPNCPVVRL | 86 | P49895 | |
| AAVREGCPGPLLATL | 576 | Q8N0W3 | |
| LVLCLQAQEGPGRGP | 16 | P55075 | |
| ELVPGDCLVLPQEGG | 311 | Q9NQ11 | |
| GKDITLQCRGPLPGV | 1176 | Q8N6C5 | |
| SGEGIFPQICLDLPR | 1486 | Q4G0P3 | |
| RCPQDTGGGINIPGV | 236 | Q9NSI5 | |
| IGPGEPLELLCNVSG | 316 | Q969P0 | |
| LCNISVRGGPPGLRL | 461 | Q969P0 | |
| ILQTPILEGRSGPGC | 551 | Q9P2G3 | |
| CNPGPERGVEFSLIG | 556 | P20023 | |
| NGPAIGLGASILPLC | 446 | Q9Y232 | |
| KELCRPEILGPGNQG | 1411 | Q8TD26 | |
| IGIKCAPGVVGPAEA | 806 | P21333 | |
| LNPLCPGAIRANGEV | 71 | P07902 | |
| QGCRGIGRCLPTLPG | 471 | Q96PX6 | |
| GLPVTQCPLGLNAKG | 481 | Q6GMR7 | |
| ARLIPFPGGAVGCGI | 251 | Q99705 | |
| GGPRAQELAQPGDLC | 461 | Q9NX74 | |
| CGTCVLLGRPQIPQG | 81 | Q96LM9 | |
| AGLVVPLDPLRGGCD | 51 | P20749 | |
| IEIGDGFLPVCSLGP | 1181 | P21817 | |
| IPAQGLLGRPGELCA | 496 | Q9BVI4 | |
| QGAAPPRCGILGLAV | 2081 | Q6ZRI0 | |
| TCGEGRPQPGLEQIK | 41 | O95868 | |
| VGGEAPVPAAVLLGC | 226 | O60391 | |
| RTCHVPGAEGPLLGV | 1066 | Q5T011 | |
| PLRICLVGPQGSGKT | 991 | Q5TCS8 | |
| LLVCPLEGPEGVRGR | 541 | Q8N1F8 | |
| IGALSLGLVVPCPER | 996 | Q6WKZ4 | |
| LLGLCQVRGGLPPFS | 206 | Q5JUK2 | |
| GCPGLSRGPVIATIV | 566 | O60279 | |
| GVSLRTLQPGCGRPQ | 16 | Q9NRR2 | |
| GFVLPCLGVHPVQGL | 61 | Q17R31 | |
| QLGEISSLPCPGGRL | 461 | Q99932 | |
| TEPGRGAPQKLCLGL | 671 | Q7Z736 | |
| PPDLGRCDGQLRGVQ | 236 | P0C7N4 | |
| GLPIKEGLSCNGPRL | 736 | Q6ZUX3 | |
| TLPGPSGNIRGVVCR | 941 | Q6ZUX3 | |
| RKLGAGEGLPQVCPA | 831 | Q9HAZ2 | |
| PALPIQPEGTRVVCG | 141 | Q8N4L2 | |
| PAAIRDGELICNGIP | 396 | Q96QT6 | |
| LALVQGVGRLECPPA | 161 | Q9HAB3 | |
| GVGRLECPPAPINGT | 166 | Q9HAB3 | |
| VTGVPREPSRGQGLC | 136 | Q5JR12 | |
| RLAPGCEPLGLLQGD | 751 | A0A0B4J2F2 | |
| RLAPGCEPLGLLQGD | 751 | P57059 | |
| GPEGIEVPCLLGISA | 601 | Q96FS4 | |
| CPNLRGIPIGMLVLG | 2606 | O75592 | |
| ILCQVSLEGDPLPGA | 1441 | P08F94 | |
| HTGGEPLRIVLAGCP | 26 | Q96EM0 | |
| VLGIGPVLGLVCVPL | 56 | Q96JT2 | |
| RLIGPNCPGVINPGE | 166 | P53597 | |
| LLTCPGPGRVAKIGD | 1256 | Q9UM73 | |
| IALQGCEVAPGFGPR | 461 | Q8TED9 | |
| LGQEPLCPRGAVLLN | 101 | Q8N910 | |
| AGLGLLSPTVVCLGP | 366 | O75333 | |
| NPREGIVIPECAPGG | 241 | Q9H4F8 | |
| GPLGPGDAVRRVLEC | 826 | Q9UPR6 | |
| GLGGLTPNPVILQDC | 101 | P04198 | |
| VCRVPGPLHSGDILG | 386 | O76050 | |
| CARFGPGGQLIKVIP | 1451 | O15027 | |
| RPRGGLVPLAEVSGC | 86 | Q9NRA0 | |
| GCNTGILPQPVGTVL | 976 | Q9UBZ9 | |
| QVVSCGGLLPGAGLP | 741 | Q96MK2 | |
| LALVQGVGRLECPPA | 161 | Q9NWF4 | |
| PVRDNQGFCIPVGLG | 476 | Q9Y2P5 | |
| QGFCIPVGLGEPGLL | 481 | Q9Y2P5 | |
| GVVPDHPVLLSGCRG | 1591 | Q7Z4S6 | |
| QPLSGLPGRALLCGQ | 651 | Q96PX9 | |
| NPRADPLVCATGLLG | 351 | Q9H2V7 | |
| PGPRALACVQLGLQL | 96 | Q9P2H5 | |
| LQGPGLGRVCEQEPG | 301 | Q6NSZ9 | |
| GRIAELPQSVGPGKC | 546 | Q5VUG0 | |
| AGINRIGELIPCSPA | 36 | Q68DE3 | |
| LNLSCRLLGGPGPVG | 1461 | Q9BZZ2 | |
| LCPLGEGPVDAGVTQ | 11 | A0A0A0MS05 | |
| LPQPVLAGVVGGVCF | 731 | Q9P2J2 | |
| AVCELDQPGLGPLVA | 866 | Q9NNW5 | |
| PVEVPGGRAVAAILG | 206 | P43489 | |
| RCGLDVPLSTLGPAV | 301 | Q9HBF4 | |
| CGLLGSLGPVPVLRF | 291 | Q14142 | |
| LGPCEPGTSVNLEGI | 366 | Q9ULD9 | |
| PSRVGLQLECGGPFL | 101 | Q5HYJ1 | |
| PAGLGAETQCEGLPV | 581 | Q8N3L3 | |
| LPCVQGQESGPLRIG | 281 | Q53SZ7 | |
| FTLPTCREGGPGLQV | 41 | Q9H8Y1 | |
| CIGQGQRGPPIILEA | 301 | Q13308 | |
| IPQGNKLLGGSVPAC | 61 | Q9NQZ8 | |
| DEAGILPIPTCGVLN | 61 | Q96GX1 | |
| GEGPSLICPEGVLKR | 76 | Q6ZS27 | |
| EGGSVPACLPLFRGQ | 386 | Q9H0D2 | |
| RVRCLQLGSPGPGPV | 151 | Q8IYS2 |